Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
A look at the R&D landscape in obesity, led by GLP-1s
If you’re feeling like the obesity pipeline filled up overnight, you’re not alone. A new analysis from IQVIA takes a look at the drugs in development.
Annalee Armstrong
,
Gabrielle Masson
Mar 19, 2024 8:00am
Top 10 pharma R&D budgets in 2023
Mar 18, 2024 5:00am
AstraZeneca melds with Fusion in $2B radiopharma buyout
Mar 19, 2024 5:52am
Neuropsych biotech Engrail closes $157M series B
Mar 19, 2024 8:00am
Bayer to take menopause drug to regulators after 3rd ph. 3 win
Mar 19, 2024 7:17am
Cutting edge: J&J MedTech taps Nvidia for surgery AI partnership
Mar 18, 2024 6:00pm
Research News
Tenaya's cardiac gene therapy boosts long-term survival in mice
Mar 18, 2024 2:33pm
Biden directs agencies to boost R&D for women's health
Mar 18, 2024 11:07am
Protease inhibitor outperforms Paxlovid protecting lungs of mice
Mar 14, 2024 6:30am
Mindstate takes trip to clinic with first AI-derived psychedelic
Mar 13, 2024 9:00am
See More Research News